Wednesday, August 26, 2020

PharmGKB and CPIC Partner with ClinGen

›
PharmGKB and CPIC have formalized a partnership with ClinGen to bring pharmacogenomics (PGx) expertise to the primarily disease-focused,...
Tuesday, August 11, 2020

New CPIC Guideline: CYP2C19 and Proton Pump Inhibitors (PPIs)

›
The CPIC Guideline for  CYP2C19  and proton pump inhibitor (PPI) dosing  is now published in Clinical Pharmacology and Therapeutics .  The a...
Monday, August 10, 2020

CYP3A5 released on PharmVar

›
PharmVar and PharmGKB are excited to announce that   CYP3A5   has been transitioned into the PharmVar database. Variation information has be...
Thursday, July 30, 2020

PharmVar user survey released

›
The Pharmacogene Variation (PharmVar) Consortium , a central repository for pharmacogene (PGx) variation that focuses on haplotype structure...
Friday, July 10, 2020

ICPC publishes GWAS analysis on platelet reactivity and cardiovascular response in patients treated with clopidogrel

›
The GWAS analysis on platelet reactivity and cardiovascular outcome for clopidogrel, the third paper by the   International Clopidogrel Pha...
Monday, July 6, 2020

PharmVar GeneFocus paper for CYP2C19 is published

›
The PharmVar GeneFocus: CYP2C19 paper, the second of the GeneFocus series, has just been published by Clinical Pharmacology & Therapeu...
Thursday, June 11, 2020

LCD announces coverage for PGx testing under Medicare

›
The Centers for Medicare and Medicaid Services (CMS) have posted a FUTURE Local Coverage Determination (LCD) for MolDX: Pharmacogenomics...